A more intensive approach to diagnosis and management of asthma in primary care: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN08067387

Enrollment

200

Registered

2006-08-17

Start date

2004-01-01

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Respiratory Asthma

Interventions

Titrate steroid dose on basis of exhaled nitric oxide versus control group receiving treatment as per current BTS (British Thoracic Society) guidelines.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Asthma 2. On treatment, providing it is a repeat prescription i.e., the patient suffers from chronic asthma 3. Aged 18-85

Exclusion criteria

Exclusion criteria: Recent exacerbation

Design outcomes

Primary

Measure	Time frame
Asthma exacerbations.	—

Secondary

Measure	Time frame
Steroid dose (area under curve).	—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 7, 2026